|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/68 | |
| C07D 401/14 | |||
| C07K 14/525 | |||
| C07D 471/00 | |||
| C07K 14/705 |
| (11) | Number of the document | 3311167 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15784066.1 |
| Date of filing the European patent application | 2015-10-22 | |
| (97) | Date of publication of the European application | 2018-04-25 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2015/074490 |
| Date | 2015-10-22 |
| (87) | Number | WO 2016/202411 |
| Date | 2016-12-22 |
| (30) | Number | Date | Country code |
| 201510758 | 2015-06-18 | GB |
| (72) |
O`CONNELL, James Philip, GB
PORTER, John Robert, GB
LAWSON, Alastair, GB
KROEPLIEN, Boris,, GB
RAPECKI, Stephen Edward, GB
NORMAN, Timothy John, GB
MCMILLAN, David James, GB
WARRELLOW, Graham John, GB
BROOKINGS, Daniel Christopher, GB
ALEXANDER, Rikki Peter, GB
|
| (73) |
UCB Biopharma SRL,
Allée de la Recherche 60, 1070 Brussels,
BE
|
| (54) | MODULATION OF MEMBERS OF THE TNF-SUPERFAMILY |
| MODULATION OF MEMBERS OF THE TNF-SUPERFAMILY |